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K. Devalia, T.R. Magee and R.B. Galland*Department of Surgery, Royal Berkshire Hospital, London Road, Reading RG1 5AN, UKPurpose. The aim of this study was to determine long-term results following successful remote superficial femoral
endarterectomy (RSFE).
Methods. RSFE is a minimally invasive technique of revascularising the superficial femoral artery. A single incision was
made over the origin of the superficial femoral artery. The endarterectomy was carried out in a closed fashion from above. The
cut end of distal atheroma was secured with a stent. Following RSFE patients were followed up with intravenous digital
subtraction angiography (IVDSA) and 3-monthly duplex scans. IVDSA was repeated if any abnormality was found.
Results. RSFE was attempted on 30 patients with 33 symptomatic legs to treat tissue loss (nZ3), rest pain (nZ3) or
intermittent claudication (nZ27). In 26 limbs it was possible to complete the RSFE satisfactorily (technical success 79%),
but during follow-up 18 later developed stenoses. Of 31 stenoses detected, 27 were treated by angioplasty. Primary patency
at 1, 2 and 5 years was 38, 31 and 16%, respectively. Primary-assisted patency at 1, 2 and 5 years was 77, 65 and 60%.
Conclusions. Primary-assisted patency following RSFE is reasonable, however, it is only achieved with life-long
surveillance and intervention. Until results can be improved the widespread use of RSFE cannot be recommended.Keywords: Remote endarterectomy; Superficial femoral artery.Introduction
Remote superficial femoral artery endarterectomy
(RSFE) is a minimally invasive means of revascularis-
ing the superficial femoral artery that provides an
alternative to femoro-popliteal bypass or angio-
plasty.1–8 The aim of this study is to determine long-
term results following successful RSFE.MethodsTechnique
The original technique was described by Moll.1 The
procedure is carried out under general anaesthetic
through a single groin incision. The common, super-
ficial and profunda femoris arteries are identified.
Following administration of 5000 IU heparin intra-
venously the origin of the superficial femoral artery is
clamped. A longitudinal arteriotomy is made in the
superficial femoral artery and the endarterectomying author. R.B. Galland, MD, FRCS, Department of
al Berkshire Hospital, London Road, Reading RG1
0262 + 04 $35.00/0 q 2005 Elsevier Ltd. All rights reserplane defined. At this point, flow is maintained
through the profunda femoris artery. A ring stripper
is passed down the superficial femoral artery in the
plane of the endarterectomy until it reaches the distal
limit of the atheroma. The ring stripper is then
removed and the atheroma cut at its distal end using
a ‘Moll ring-cutter’ (Medtronic, USA). The ather-
omatous core is removed and the distal end secured
by means of a Palmaz stent (J and J Interventional,
USA). A 2.9-cm stent is used with 8 mm maximal
diameter mounted on a 5-mm balloon. Once the stent
is in position the proximal end is funnelled by
oversizing the top of the stent using an 8-mm balloon.
Thus, blood flows smoothly into the popliteal artery.
Following completion angiography, common and
profunda femoris arteries are clamped. The arteriot-
omy in the superficial femoral artery is extended into
the common femoral artery, any residual atheroma is
removed and the arteriotomy closed with a vein patch.
The procedure takes about 90 min to complete.
The potential problem with this technique is that
when the guidewire is passed from above, prior to
placing the stent, the wire can cause further dissection
preventing cannulation of distal lumen. This occurred
in the first two patients on whom the procedure wasEur J Vasc Endovasc Surg 31, 262–265 (2006)
doi:10.1016/j.ejvs.2005.10.019, available online at http://www.sciencedirect.com onved.
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such that a guidewire was passed into the popliteal
artery, distal to the occlusion, under local anaesthetic
prior to the operative procedure described above.9 The
advantage is that the guidewire remains in the lumen
of the vessel throughout and having a guidewire in
popliteal artery distal to the occlusion also defines
accurately the occlusion’s lower limit.Follow-up
Ankle-brachial pressure index (ABPI) was carried out
before and following the procedure. All patients had
an intravenous digital subtraction angiogram (IVDSA)
at 24 h. Duplex scanning of the superficial femoral
artery was carried out at 3-monthly intervals and a
further IVDSA carried out if any abnormality was
detected. Follow-up was 3–84 months. Patency was
calculated by the life table method.0
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Fig. 1. Timing of development of first stenosis.Results
RSFE was attempted on 30 patients (22 men). Seven
had ischaemic heart disease, eight were diabetic and
their median age was 64 years (range: 45–84 years).
Thirty-three symptomatic legs were treated. All
patients had intermittent claudication. In addition,
three had rest pain and three ulceration or gangrene.
All patients were on best medical treatment to control
risk factors. Patients with intermittent claudication
had life-style limiting symptoms, which had failed to
improve with a 3-month conservative regimen.
Previous interventions included percutaneous trans-
luminal angioplasty in six, femoro-popliteal bypass in
one, superficial femoral artery endarterectomy in one,
femorofemoral cross-over graft in one and abdominal
aortic aneurysm repair in one.
In seven cases it was impossible to complete the
endarterectomy. This included two patients who had
previously had operative procedures on the superficial
femoral artery. In three others the vessel was heavily
calcified and the procedure could not be completed. In
two patients the superficial femoral artery was
perforated during endarterectomy. These limbs all
underwent successful femoro-popliteal bypass under
the same anaesthetic. These cases are not considered
further.
In 26 limbs it was possible to complete the RSFE
satisfactorily. Follow-up was 3–84 months.
In 22 of 26 instances where the RSFE was
successfully completed the patient was discharged
within 24 h. One patient required an extra night inhospital because of groin pain. Two patients required
re-exploration of the groin due to bleeding from the
vein patch and one of these patients stayed in hospital
an extra 24 h. Two patients stayed in for anticoagula-
tion. One patient in whom the run off was thought to
be poor had heparinisation for 48 h. The other patient
had an artificial heart valve and had previously been
on warfarin, which required stabilisation following
RSFE.Duplex surveillance and stenosis development
Any patient in whom a peak systolic velocity (PSV)
greater than 2.5 was identified on duplex scanning
underwent an IV DSA. In 18 endarterectomised
superficial femoral arteries 31 stenoses were ident-
ified. The stenoses developed anywhere along the
endarterectomised segment or distally in the region of
stent. Fig. 1 shows that the majority of stenoses
develop in the first 18 months; however, they
continued to develop throughout follow-up. Percuta-
neous transluminal angioplasty (PTA) was carried out
on any stenosis with PSV greater than 2.5. Fig. 2 shows
the total number of stenoses recorded.Patency
In 11 cases the artery occluded. Eight occlusions were
within the first 2 years. One patient remained
asymptomatic following occlusion. Two patients
underwent a major amputation following occlusion,
both originally presented with rest pain or gangrene.
A further three patients underwent femoro-popliteal
bypass. In one patient the artery occluded at 5 years
and he developed wet gangrene of the foot eventually
leading to death from sepsis. In one patient the ABPI
fell from 0.62 pre-RSFE to 0.4 following occlusion soon
after surgery. He originally presented withEur J Vasc Endovasc Surg Vol 31, 3 2006
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Fig. 2. Total number of stenoses.
K. Devalia et al.264intermittent claudication at 50 yards and following
occlusion he complained of a white, numb foot.
Angiography confirmed a previously undetected
iliac stenosis. He underwent PTA of the iliac stenosis
followed by thrombectomy of the superficial femoral
artery. In the remaining cases, following occlusion
symptoms were no worse than before RSFE.
Patency of RSFE is shown in Fig. 3. The primary
patency at 1, 2 and 5 years was 38, 31 and 16%,
respectively. Primary-assisted patency at 1, 2 and 5
years was 77, 65 and 60%, respectively.Discussion
Generally lower limb revascularisation is considered
when optimisation of cardiovascular risk factors and
an exercise program have failed in patients with
intermittent claudication and for those who present
with rest pain or tissue loss. Femoro-popliteal bypass
using vein leads to better results than endarterectomy,
however, the latter may produce results equivalent to a
synthetic bypass. The use of endarterectomy, whether
open, semi-closed or remote, has advantages of thereFig. 3. Primary and primary-assisted patency following
successful RSFE. Bars represent standard errors of the mean.
Eur J Vasc Endovasc Surg Vol 31, 3 2006being no synthetic material for potential infection, the
procedure can be used in absence of vein, or veins can
be preserved. Following occlusion of the endarter-
ectomy, the limb is no worse than it was pre-
operatively in contrast to occlusion of polytetrafluor-
oethylene (PTFE) grafts which can result in symptoms
worse than those originally due to thrombosis of run-
off vessels.4
Following RSFE primary-assisted patency was
comparable to primary patency following synthetic
above-knee femoro-popliteal bypass. The primary and
primary-assisted patency at 5 years was 16 and 60%,
respectively. Rosenthal et al.10 reported a primary-
assisted patency of 88% at 33 months and Moll et al.3
described 86% primary-assisted patency at 2 years.
Superficial femoral artery stenosis development is a
major problem after RSFE. Stenoses develop in 30% of
vein grafts mostly within the 1st year of operation.11
Our study shows that in approximately two-thirds of
patent arteries significant stenoses developed after
RSFE, an incidence slightly higher than previously
reported as 23–46%.2,10,12 We adopted an aggressive
policy for dealing with stenoses as in an early case
thrombosis developed very soon after a stenosis was
identified.
There are obvious short term advantages with RSFE
such as cost advantages due to a short hospital stay.
This is comparable with that expected following PTA
and better than would be expected after femoro-
popliteal bypass. The other advantage is that if a vein
is present, it can be preserved for future use. However,
the cost advantages are largely offset by lifelong
duplex surveillance and PTA to maintain patency.4
Currently there are multicentre studies underway to
evaluate feasibility and efficacy of an innovative new
covered stent and adjustable deployment system
(aSpire trade mark covered stent, Vascular Architects
Inc., San Jose, USA) in combination with RSFE for the
treatment of long segment femoro-popliteal occlusive
disease. The medium term follow up appears favour-
able with cumulative primary and primary-assisted
patency rates of 60 and 70%, respectively, at 18
months.13,14
In conclusion, based on these data RSFE cannot be
recommended for widespread use.References
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